US EditionPublished • loading... • Updated
Boston Scientific receives US FDA clearance for TheraSphere 360 any day dosing
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Boston Scientific receives US FDA clearance for TheraSphere 360 any day dosing
TheraSphere 360 Boston Scientific has announced that it has received US Food and Drug Administration (FDA) clearance for its any day dosing feature on its TheraSphere 360 yttrium-90 (Y-90) management platform. In a recent press release the company shares that care teams who treat patients with liver cancer using Boston Scientific’s potent radiation therapy, TheraSphere Y-90, will now have more options to administer it any day of the week. “The F…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
